ATE530194T1 - Immunomodulierende zusammensetzung die eine partikelfraktion von bakteriellen mechanischen lysates enthält - Google Patents

Immunomodulierende zusammensetzung die eine partikelfraktion von bakteriellen mechanischen lysates enthält

Info

Publication number
ATE530194T1
ATE530194T1 AT03723085T AT03723085T ATE530194T1 AT E530194 T1 ATE530194 T1 AT E530194T1 AT 03723085 T AT03723085 T AT 03723085T AT 03723085 T AT03723085 T AT 03723085T AT E530194 T1 ATE530194 T1 AT E530194T1
Authority
AT
Austria
Prior art keywords
bacterial
composition containing
particle fraction
lysates
mechanical
Prior art date
Application number
AT03723085T
Other languages
English (en)
Inventor
Giovanni Melioli
Roberto Fasani
Original Assignee
Medi Service S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medi Service S R L filed Critical Medi Service S R L
Application granted granted Critical
Publication of ATE530194T1 publication Critical patent/ATE530194T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03723085T 2003-04-30 2003-04-30 Immunomodulierende zusammensetzung die eine partikelfraktion von bakteriellen mechanischen lysates enthält ATE530194T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2003/000267 WO2004096270A1 (en) 2003-04-30 2003-04-30 Immunomodulating composition comprising a particulate fraction of bacterial mechanical lysates

Publications (1)

Publication Number Publication Date
ATE530194T1 true ATE530194T1 (de) 2011-11-15

Family

ID=33397889

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03723085T ATE530194T1 (de) 2003-04-30 2003-04-30 Immunomodulierende zusammensetzung die eine partikelfraktion von bakteriellen mechanischen lysates enthält

Country Status (5)

Country Link
EP (1) EP1617867B1 (de)
AT (1) ATE530194T1 (de)
AU (1) AU2003230228A1 (de)
ES (1) ES2375180T3 (de)
WO (1) WO2004096270A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008011884A1 (es) * 2006-07-27 2008-01-31 Ramirez Castro Angel Dr Nuevo inmunomodulador
BRPI1100857A2 (pt) * 2011-03-18 2013-05-21 Eduardo Nowill Alexandre agente imunomodulador e suas combinaÇÕes, seu uso e mÉtodo imunoterÁpico para a recontextualizaÇço, reprogramaÇço e reconduÇço do sistema imune em tempo real
WO2012173163A1 (ja) * 2011-06-14 2012-12-20 有限会社バイオメディカルリサーチグループ 菌体破砕物及びその配合物
RU2528877C2 (ru) * 2012-01-11 2014-09-20 Минигаян Садреевич Шарафутдинов Способ лечения больных с онкологическими заболеваниями и/или иммунодепрессиями
MX2019009689A (es) * 2017-02-13 2019-12-18 Eduardo Nowill Alexandre Composición inmunogénica para la modulación del sistema inmune y métodos para tratar infecciones bacterianas en un sujeto.
CN110124019B (zh) * 2019-04-22 2022-09-23 海南医学院 细菌化肿瘤细胞疫苗及其制备方法
CA3200999A1 (en) * 2020-12-14 2022-06-23 Miguel Angel Barajas Velez Compositions comprising bacteria for cancer immunotherapy
CN116440173A (zh) * 2023-06-01 2023-07-18 复旦大学附属中山医院 细菌的冻干溶解产物在制备治疗肺结节的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2307542A1 (fr) * 1975-04-14 1976-11-12 Synthelabo Nouvelle preparation immunostimulante
FR2822071B1 (fr) * 2001-03-15 2005-07-01 Pf Medicament Utilisation d'une fraction membranaire de bacteries a gram negatif pour induire la maturation des cellules dendritiques

Also Published As

Publication number Publication date
ES2375180T3 (es) 2012-02-27
WO2004096270A1 (en) 2004-11-11
EP1617867A1 (de) 2006-01-25
AU2003230228A1 (en) 2004-11-23
EP1617867B1 (de) 2011-10-26

Similar Documents

Publication Publication Date Title
AU6304394A (en) Urethanes and ureas that induce cytokine production
BR0209489A (pt) Composições farmacêuticas
UA85993C2 (ru) Конъюгат, который содержит бактериальный суперантиген и антительную составную, фармацевтическая композиция, которая его содержит, и способ лечения рака у млекопитающего
ATE279934T1 (de) Peptidextrakt aus lupinen und pharmazeutische oder kosmetische oder pharmaco-nahrungsmittel zusammensetzung, die so ein extrakt enthalten
MX2021007392A (es) Regimen de dosificacion y combinacion farmaceutica que comprende derivados de 3-(1-oxoisoindolin-2-il)piperidina-2,6-diona.
BG64475B1 (bg) Ципразидонови соли
HUP0401241A3 (en) Novel cyclohexyl sulphones, process for their preparation and pharmaceutical compositions containing them
ATE519501T1 (de) Rekombinanter anti-cd40 antikörper und dessen anwendungen
SE9901875D0 (sv) Novel compounds
TR200101310T2 (tr) Farmasötik moksifloksasin preparatı.
HUS1800013I1 (hu) Cladribine tartalmú orális gyógyászati készítmény
WO2003092624A3 (en) Use of heat shock proteins to enhance efficacy of antibody therapeutics
EP4302778A4 (de) Pharmazeutische zusammensetzung mit anti-tslp-antikörper
TW200505875A (en) Novel compounds
CY1109465T1 (el) Νεες φαρμακευτικες φαρμακοτεχνικες μορφες μονταφινιλης
EP1423137A4 (de) Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
HK21795A (en) Cross-protective human monoclonal antibody compositions
AU2003230228A1 (en) Immunomodulating composition comprising a particulate fraction of bacterial mechanical lysates
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
ATE237343T1 (de) Retropeptide, antikörper dagegen und deren verwendungen in der impfung und in vitro diagnostik
BG103260A (en) The application of 1-hydroxy-2-pyridons for the treatment of seborrheic dermatitis
SE0300457D0 (sv) Novel compounds
DE602004008051D1 (de) Aus einer bifidobakterien-kultur gewonnener immunomodulator und diesen enthaltende zusammensetzungen
DE60032119D1 (de) Bakterienwandfraktionen mit adjuvansaktivität
DE3260277D1 (en) Peptide antibiotic, component b, process for its preparation and its use in medicines

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties